intern
travel
human
encroach
previous
isol
area
increas
potenti
emerg
new
infecti
diseas
popul
like
suscept
new
infecti
diseas
also
increas
size
past
three
decad
seen
outbreak
diseas
caus
parvovirus
nipah
viru
circovirus
prion
infecti
pathogen
formid
oppon
adapt
new
host
caus
variant
diseas
within
new
host
mani
also
resist
current
inactiv
techniqu
order
prevent
contain
outbreak
pathogen
emerg
must
identifi
quickli
effici
research
ongo
global
surveil
therefor
primari
import
effect
protect
blood
suppli
bloodbas
therapi
research
includ
investig
improv
techniqu
detect
screen
viral
inactiv
well
way
reduc
patient
exposur
infecti
pathogen
via
therapeut
agent
proactiv
devot
appropri
resourc
infecti
diseas
contain
prevent
prior
epidem
perceiv
essenti
public
health
polici
cost
effect
semin
hematol
suppl
n
wake
signific
stride
vaccin
antibiot
follow
world
war
ii
public
health
commun
believ
infecti
diseas
could
effect
control
howev
new
infecti
pathogen
emerg
public
health
expert
could
longer
believ
threat
infecti
diseas
reced
fact
potenti
emerg
new
infecti
diseas
increas
result
commonplac
extens
intern
travel
steadi
human
encroach
previous
isol
area
infecti
diseas
categor
emerg
base
either
document
increas
incid
human
past
two
decad
evid
potenti
increas
near
futur
evid
would
includ
report
pathogen
demonstr
abil
increas
host
rang
jump
speci
infect
new
popul
emerg
infecti
pathogen
recent
decad
includ
human
immunodefici
viru
hiv
avianvari
influenza
sever
acut
respiratori
syndrom
sar
viru
west
nile
viru
dengu
fever
monkeypox
parvoviru
nipah
viru
ebola
viru
variant
creuzfeldtjakob
diseas
vcjd
infecti
diseas
threat
blood
suppli
clinic
present
associ
mani
infecti
diseas
sever
enough
infect
patient
like
blood
donor
exampl
ebola
viru
bloodborn
infect
person
like
donat
blood
becom
ill
quickli
howev
infecti
diseas
hiv
vcjd
long
latent
infecti
period
person
donat
blood
knowledg
infect
latter
type
infecti
diseas
well
other
mild
clinic
sequela
potenti
infect
blood
suppli
donat
transmit
hemophilia
commun
person
blood
product
figur
multipl
argument
support
belief
inevit
emerg
addit
infecti
diseas
princip
reflect
follow
five
factor
adapt
virus
allow
viral
mutat
enabl
defens
aggress
adapt
new
environ
promot
develop
drug
resist
achiev
crossspeci
transmiss
human
encroach
previous
unexplor
habitat
increas
exposur
new
agent
increas
number
suscept
host
eg
elderli
hivinfect
chemotherapi
patient
offer
greater
opportun
infecti
pathogen
diseas
transmiss
advanc
pathogen
screen
technolog
result
increas
sensit
result
better
detect
novel
previous
unrecogn
pathogen
current
unknown
biolog
factor
may
becom
evid
futur
refer
xfactor
parvovirus
parvovirus
nonlipidenvelop
singlestrand
dna
virus
prefer
infect
lyse
rapidli
divid
cell
continu
viral
threat
current
parvoviru
known
pathogen
parvoviru
human
capabl
caus
sever
diseas
typic
caus
selflimit
febril
ill
erythema
infectiosum
also
call
slap
cheek
syndrom
fifth
diseas
howev
patient
immunosuppress
hematolog
disord
caus
aplast
crise
parvovirus
potenti
threat
human
health
safeti
alter
hostspecif
protein
effect
crossspeci
transmiss
felin
parvoviru
fplv
exampl
caus
felin
panleukopenia
diseas
ie
felin
distemp
alter
host
specif
mid
late
outbreak
new
diseas
dog
symptom
similar
felin
distemp
includ
high
mortal
rate
wide
accept
hypothesi
mutat
fplv
close
relat
viru
infect
mink
fox
caus
emerg
new
viru
canin
parvoviru
essenti
fplv
jump
speci
natur
resist
dog
result
rapid
global
epidem
stop
within
year
develop
new
vaccin
dog
use
previous
avail
cat
vaccin
abil
parvovirus
relat
virus
mutat
cross
human
particularli
alarm
difficult
elimin
parvoviru
nonlipidenvelop
virus
highli
resist
multipl
viral
inactiv
protocol
use
blood
product
process
eg
pasteur
heat
treatment
solventdeterg
techniqu
effect
lipidenvelop
virus
parvoviru
contamin
extens
document
anim
product
tryp
sl
stanley
sin
use
prepar
recombin
factor
serum
also
transmit
asymptomat
blood
donor
numer
report
transmiss
transfus
virusinactiv
purifi
clot
factor
concentr
mani
case
seriou
clinic
consequ
dna
found
viral
attenu
plasmaderiv
clot
factor
viii
fviii
ix
fix
firstgener
recombin
fviii
rfviii
therapi
contamin
human
albumin
use
stabil
like
sourc
dna
clot
factor
therapi
also
infect
patient
receiv
contamin
intraven
immun
globulin
infus
purif
techniqu
involv
polymeras
chain
reaction
pcr
screen
remov
infect
blood
reduc
presenc
parvoviru
blood
product
elimin
entir
yet
report
develop
parvoviru
diseas
subsequ
transfus
recombin
prepar
possibl
elimin
effect
elimin
techniqu
develop
alway
concern
animalor
humanderiv
product
could
serv
sourc
transmiss
malaysia
septemb
june
suffer
sudden
outbreak
enceph
affect
exhibit
reduc
conscious
brain
stem
dysfunct
author
determin
epicent
outbreak
nipah
river
villag
initi
case
contact
pig
infect
respiratori
diseas
diseas
spread
throughout
malaysia
farmer
sold
pig
across
countri
result
epidem
caus
case
acut
enceph
death
mortal
approxim
new
viru
identifi
belong
paramyxoviru
famili
measl
mump
name
nipah
villag
origin
evid
suggest
viral
reservoir
nipah
fruit
bat
whose
urin
nipah
isol
conjectur
bat
feed
fruit
orchard
adjac
piggeri
nipah
urin
defec
onto
fruit
pig
ate
fruit
contract
viru
close
proxim
pig
piggeri
foster
pigtopig
transmiss
nipah
viru
transmit
human
primarili
direct
contact
infect
pig
contamin
pig
tissu
pig
also
transfer
nipah
viru
cat
dog
hors
epidem
nipah
bangladesh
although
sourc
viru
unclear
nipahposit
bat
found
evolut
nipah
viru
emphas
real
threat
crossspeci
transmiss
circovirus
nonlipidenvelop
singlestrand
circular
dna
virus
pathogen
within
anim
host
could
becom
pathogen
within
human
circovirus
extraordinarili
small
genom
base
smallest
virus
known
circoviru
famili
includ
porcin
circoviru
pcv
chicken
anemia
viru
cav
tt
viru
ttv
affect
human
although
time
ttv
abil
caus
diseas
unclear
bloodborn
ttv
display
substanti
genet
divers
unknown
whether
genet
variabl
could
lead
increas
potenti
caus
diseas
detect
rate
ttv
dna
human
high
ttv
infect
may
univers
fact
individu
infect
multipl
genotyp
ttv
although
potenti
repercuss
infect
unknown
ttv
transmit
blood
fecalor
rout
debat
motherinf
transmiss
ttv
particular
concern
circovirus
demonstr
high
degre
plastic
anim
circovirus
caus
sever
diseas
respect
host
addit
circovirus
nonlipidenvelop
small
genom
resist
standard
inactiv
method
includ
irradi
prion
insolubl
cellular
protein
particl
lack
nucleic
acid
therefor
depend
gene
factor
transmiss
trait
human
prion
protein
gene
prnp
chromosom
usual
encod
normal
prion
protein
instanc
posttransl
conform
chang
occur
creat
abnorm
transmiss
particl
prp
sc
term
prion
believ
respons
human
least
five
clinic
diseas
kuru
gerstmannstrausslerscheink
diseas
fatal
famili
insomnia
creutzfeldtjakob
diseas
cjd
variant
cjd
vcjd
prion
also
present
speci
anim
prion
caus
scrapi
bovin
spongiform
encephalopathi
bse
mad
cow
diseas
chronic
wast
diseas
felin
encephalopathi
prion
diseas
develop
spontan
like
transmit
dietari
bloodborn
contamin
vcjd
may
transmit
consumpt
contamin
meat
blood
transfus
classic
cjd
transmit
contamin
human
pituitari
hormon
dura
matter
draft
corneal
graft
surgic
instrument
given
characterist
prion
transmiss
vcjdassoci
prion
present
alarm
real
concern
patient
reliant
blood
product
includ
patient
hemophilia
decemb
case
vcjd
report
worldwid
although
major
case
occur
unit
kingdom
vcjd
also
identifi
franc
ireland
itali
unit
state
canada
patient
vcjd
initi
present
psychiatr
symptom
depress
withdraw
anxieti
cognit
impair
persist
pain
sensori
symptom
eventu
symptom
progress
dementia
death
median
age
death
year
old
indic
vcjd
frequent
occur
young
peopl
suscept
vcjd
clinic
symptom
diseas
time
appear
symptom
determin
polymorph
codon
prnp
individu
heterozyg
codon
may
infect
still
incub
period
case
report
detail
later
demonstr
vcjd
transmit
patient
incub
period
therefor
though
incid
vcjd
decreas
worldwid
sinc
latent
infect
may
still
present
threat
transmiss
remain
blood
transfus
possibl
respons
two
known
case
vcjd
one
case
patient
receiv
transfus
red
cell
surgeri
one
unit
transfus
blood
donat
develop
symptom
vcjd
year
month
blood
donat
die
year
transfus
recipi
manifest
clinic
symptom
vcjd
die
month
later
second
case
elderli
patient
receiv
transfus
red
blood
cell
blood
donor
develop
symptom
vcjd
month
donat
die
vcjd
confirm
autopsi
recipi
patient
die
year
transfus
show
evid
neurolog
diseas
nonetheless
postmortem
patient
shown
posit
vcjd
respons
vcjd
threat
unit
kingdom
announc
patient
hemophilia
congenit
bleed
disord
risk
vcjd
announc
notabl
financi
psycholog
impact
sinc
patient
hemophilia
congenit
bleed
disord
might
infect
vcjd
consid
capabl
transmit
other
therefor
unit
kingdom
implement
new
standard
care
includ
dispos
instrument
use
patient
hemophilia
easili
disinfect
eg
endoscop
dental
equip
new
standard
care
costli
dentist
refus
treat
patient
hemophilia
countri
also
forc
confront
spread
prion
diseas
octob
french
health
ministri
announc
blood
donor
still
aliv
develop
vcjd
within
month
french
author
announc
discoveri
blood
donat
anoth
individu
later
diagnos
vcjd
belgian
red
cross
use
frenchsourc
plasma
one
infect
donor
produc
factor
viii
ix
although
yet
report
vcjd
transmiss
person
hemophilia
clear
continu
vigil
necessari
intervent
improv
blood
safeti
expens
compar
cost
intervent
benefit
given
qualityadjustedlif
year
qali
calcul
improv
blood
safeti
hiv
antibodi
test
develop
introduc
mid
million
transfus
year
unit
state
estim
preval
hiv
one
blood
donor
cost
per
qali
intervent
calcul
contrast
cost
per
qali
antigen
test
hiv
estim
million
hiv
nat
million
differ
costeffect
reflect
decreas
preval
hiv
blood
donor
popul
howev
new
defens
intervent
could
cost
effect
new
bloodborn
pathogen
enter
blood
suppli
figur
cost
pathogen
screen
techniqu
must
consid
relat
potenti
futur
cost
diseas
treatment
becom
infect
medic
cost
associ
treatment
viral
infect
substanti
cost
involv
treat
patient
hemophilia
coinfect
hiv
nearli
time
greater
cost
without
coinfect
costeffect
costutil
analys
import
develop
resourc
alloc
decis
mani
resourc
use
ensur
transfus
donat
blood
carri
nearli
zero
risk
econom
evalu
techniqu
ensur
blood
safeti
show
intervent
may
cost
effect
conclus
limit
impact
develop
blood
polici
decis
societi
appear
accept
valu
protect
nation
blood
suppli
pathogen
infect
could
transcend
standard
cost
consider
addit
lesson
appear
absorb
hiv
epidem
economicsbas
decis
could
control
fact
inadvert
contribut
spread
epidem
final
policymak
fear
litig
decis
respect
infecti
diseas
control
later
shown
irrespons
continu
vigil
may
present
major
financi
burden
current
consid
worthwhil
face
continu
emerg
new
pathogen
potenti
transmiss
blood
blood
product
import
attitud
reinforc
year
come
incid
emerg
pathogen
unlik
diminish
cost
pathogen
control
like
increas
vigil
requir
establish
public
health
infrastructur
oper
appropri
respons
crisi
need
includ
improv
surveil
constantli
review
updat
respond
emerg
diseas
sinc
emerg
pathogen
occur
worldwid
effect
surveil
must
global
current
center
diseas
control
prevent
collabor
world
health
organ
surveil
report
emerg
infecti
diseas
ensur
emerg
pathogen
identifi
quickli
effici
research
new
technolog
primari
import
effect
protect
blood
suppli
blood
product
techniqu
includ
improv
detect
blood
screen
viral
inactiv
process
well
reduc
exposur
patient
anim
protein
capabl
transmit
infecti
pathogen
current
avail
hemophilia
therapi
vari
level
exposur
vulner
contamin
bloodborn
pathogen
reflect
degre
incorpor
compon
humanor
animalderiv
plasma
albumin
wherev
possibl
level
vulner
reduc
therapi
least
exposur
humanor
animalderiv
protein
therefor
lowest
level
vulner
made
wide
avail
continu
vigil
nationsand
worldsblood
suppli
critic
long
infecti
diseas
possibl
say
far
forese
futur
infecti
pathogen
formid
oppon
abil
chang
genet
blueprint
adapt
new
host
caus
variant
diseas
within
new
host
global
increas
risk
pathogen
emerg
popul
like
suscept
new
infecti
diseas
grow
size
proactiv
devot
appropri
resourc
infecti
diseas
contain
prevent
prior
epidem
perceiv
essenti
public
health
polici
costeffect
